Eli Lilly & Co. Earnings Dividend

Eli Lilly & Co.’s revenue jumped 47.67% since last year same period to $22974Mn in the Q2 2026. On a quarterly growth basis, Eli Lilly & Co. has generated 16.04% jump in its revenue since last 3-months.

Eli Lilly & Co.’s net profit jumped 25.34% since last year same period to $7095Mn in the Q2 2026. On a quarterly growth basis, Eli Lilly & Co. has generated -4.07% fall in its net profits since last 3-months.

Eli Lilly & Co.’s net profit margin fell -15.12% since last year same period to 30.88% in the Q2 2026. On a quarterly growth basis, Eli Lilly & Co. has generated -17.33% fall in its net profit margins since last 3-months.

Eli Lilly & Co.’s earning per share (EPS) estimates for the current quarter stand at 6.01 - a -11.49% fall from last quarter’s estimates.

Eli Lilly & Co.’s earning per share (EPS) estimates for the current year stand at 6.01.

Eli Lilly & Co.’s earning per share (EPS) jumped 32.81% since last year same period to 8.38 in the Q2 2026. This indicates that the Eli Lilly & Co. has generated 32.81% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Eli Lilly & Co. declared 1.73 dividend per share during the earnings announcement for Q2 2026.